These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 8588437)

  • 41. [Limits of assistant liability in delivery by an assisting physician in residency].
    Bebong B; Andreas M
    Geburtshilfe Frauenheilkd; 1995 Aug; 55(8):M90-1. PubMed ID: 7557214
    [No Abstract]   [Full Text] [Related]  

  • 42. Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.
    Manthei JR; Hathaway CR; Grant MA; Chung DD
    Food Drug Law J; 2006; 61(2):273-7. PubMed ID: 16903032
    [No Abstract]   [Full Text] [Related]  

  • 43. The Canadian perspective: trends in drug and medical device class actions in Canada.
    Vernon W
    Food Drug Law J; 2006; 61(3):569-76. PubMed ID: 16989040
    [No Abstract]   [Full Text] [Related]  

  • 44. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
    Breslow LH
    Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effective legal reform and the malpractice insurance crisis.
    Anderson RE
    Yale J Health Policy Law Ethics; 2005; 5(1):343-55. PubMed ID: 15742580
    [No Abstract]   [Full Text] [Related]  

  • 46. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 47. Managed care: a pothole in the road to medical malpractice insurance reform?
    Fouassier JG
    Healthc Financ Manage; 2007 Jul; 61(7):42-5. PubMed ID: 17687969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Professional liability insurance reform: epilogue.
    Aleali SH
    Conn Med; 2004; 68(6):403-4. PubMed ID: 15266890
    [No Abstract]   [Full Text] [Related]  

  • 49. [The physician's liability from the viewpoint of the insurance medicine representative. Intermediate report of a study].
    Reichenbach M
    Med Welt; 1982 Sep; 33(37):1262-66. PubMed ID: 7132680
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapeutic trial, clinical research and therapeutic freedom--legal boundaries].
    Deutsch E
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):698-700; discussion 701. PubMed ID: 9527472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 52. Defense of truth never rests in liability debate.
    Palmisano DJ
    Md Med; 2004; 5(2):52. PubMed ID: 15227954
    [No Abstract]   [Full Text] [Related]  

  • 53. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA
    Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
    [No Abstract]   [Full Text] [Related]  

  • 54. Is liability possible for forensic psychiatrists?
    Weinstock R; Garrick T
    Bull Am Acad Psychiatry Law; 1995; 23(2):183-93. PubMed ID: 8605402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Organizational liabilities in the clinic and general practice--medical standards in structural and organizational changes. Einbecker recommendations of the German Society of Medical Law (DGMR) e.V].
    Lippert HD;
    Chirurg; 2006 Jun; Suppl():174-7. PubMed ID: 17855920
    [No Abstract]   [Full Text] [Related]  

  • 56. Study agreements and budgets.
    McJilton JS
    Epilepsy Res Suppl; 1993; 10():185-91. PubMed ID: 8251095
    [No Abstract]   [Full Text] [Related]  

  • 57. Whose liability is it? The pharmacist on trial.
    Am Pharm; 1994; NS34 Suppl 1():1-16; quiz 17-9. PubMed ID: 7726096
    [No Abstract]   [Full Text] [Related]  

  • 58. Professional liability: to have? Or not to have? Part 2: Qualified immunity.
    Lira CP
    Tex Nurs; 1996 Mar; 70(3):13. PubMed ID: 8715630
    [No Abstract]   [Full Text] [Related]  

  • 59. Contract research organizations (CROs) may be the next trend in clinical trials liability.
    Valdes S; McGuire P
    J Biolaw Bus; 2004; 7(3):11-5. PubMed ID: 15460602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Legal liability of the obstetrician and damage to the child from the legal viewpoint].
    Schlund GH
    Gynakologe; 1992 Jun; 25(3):191-5. PubMed ID: 1505801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.